Novabay Pharmaceuticals Inc

ASE:NBY   3:58:51 PM EDT
0.53
-0.01 (-2.44%)
Products, Earnings Announcements

NovaBay Pharmaceuticals To Acquire DERMAdoctor In $15 Mln Deal

Published: 09/28/2021 12:22 GMT
Novabay Pharmaceuticals Inc (NBY) - Novabay Pharmaceuticals Signs Agreement to Acquire Dermadoctor.
Novabay Pharmaceuticals Inc - Operational Synergies and Diversified Product Portfolio Expected to Drive Profitability.
Novabay Pharmaceuticals Inc - Acquisition Has Potential to Double Topline Revenue in 2022.
Novabay Pharmaceuticals Inc - Deal for For a Purchase Price of $15.0 Million,.
Revenue is expected to be $2.6 Million
Adjusted EPS is expected to be -$0.04

Next Quarter Revenue Guidance is expected to be $3.45 Million
Next Quarter EPS Guidance is expected to be -$0.04

More details on our Analysts Page.